Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Beginners often wonder which card type to choose. This intro compares secured vs unsecured options and provides starter tips.
22,834 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
U.S. stocks rose as markets entered a holiday-shortened week ahead of the Fourth of July. The S&P 500 led gains while...
Rivian ranks at the bottom of the JD Power 2026 Initial Quality Study, recording 246 problems per 100 vehicles in the...
A single metric helps explain the uneasy mood among Americans: the declining share of income going to workers as prof...
Hometap expands its home equity investment offering to Georgia, Montana, Tennessee, Idaho, and Delaware, signaling co...
Chip shares jumped as risk appetite returned to markets, with Intel and AMD leading a broader move higher on AI infra...
Retirement income planning isn’t just about growth; it’s about dependable cash flow. This guide shows how a Vanguard ...
A rare bipartisan bill moving through Congress would permanently establish a national AI research resource, reshaping...
US spot Bitcoin ETFs posted another day of outflows on June 30, extending a nine-day streak and signaling a broader c...
Massive passive flows into the Russell 2000 through IWM are lifting small caps, even as investors await the next Fed ...
Two financial plans, one patient retiree, and a surprising reframe: treating Social Security as a bond changes how a ...